That gives you roughly four to five months of weekly injections without revisiting the same spot, assuming you use the abdomen exclusively
Recommended monitoring includes: Complete blood count, comprehensive metabolic panel Vitamin B12, folate, iron studies, vitamin D, calcium, parathyroid hormone Thiamine in patients with persistent vomiting Protein intake assessment and albumin/prealbumin levels Contraindications include personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, as GLP-1 receptor agonists carry a boxed warning based on rodent studies showing thyroid C-cell tumors
Always consult your doctor before starting, adjusting, or stopping any medication
TRIUMPH-1 discontinuation rates were 4.1%, 6.9%, and 11.3% on the 4 mg, 9 mg, and 12 mg arms
Draw to the 100-unit mark twice
Compared with GLP-1, dual agonists can avoid the degradation of dipeptidyl peptidase-4, thereby prolongating drug administration